By considering the high frequency of p53 mutations in HPV-negative HNSCC and the hypoxia observed in these tumours, the co-operation between p53 mutants and HIF-1 signalling might represent a meaningful avenue for clinical investigation. The gene discussed is HIF1A; the disease is neoplasm.